mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.15 |
0.6 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |